Screening Patterns of Nonalcoholic Fatty Liver Disease in Children with Obesity in Canadian Primary Care: A Cross-Sectional Study

Table 1

Eligible NAFLD screening population.

Characteristics	Total eligible, n(%) (N = 9888)
Age, years
9–12	3967 (40.1)
13–18	5921 (59.9)
Sex
Male	5465 (55.3)
Female	4423 (44.7)
Location
Rural	1887 (19.5)
Urban	7803 (80.5)
Missing	198
BMI, percentile
≥95^th–<99^th (obese)	7658 (77.5)
≥99^th (severe obesity)	2230 (22.6)
Preexisting conditions
Diabetes	90 (0.91)
Hypertension	215 (2.2)
Dyslipidemia	272 (2.8)
Depression/Anxiety	835 (8.4)
PCOS	24 (0.24)
Prior medications
Antipsychotics	272 (2.8)
Anxiolytics	188 (1.9)
Antidepressants	1147 (11.6)
Antihypertensives	127 (1.3)
Antidiabetics	62 (0.60)
Prior liver panel
AST and/or ALT	1685 (17.0)
Prior primary healthcare utilization, one year average	3.99 (3.96)^†
Prior specialist referral
Gastroenterology	85 (0.9)
Endocrinology	119 (1.2)
Pediatrics	1296 (13.1)

^†Reported as mean (standard deviation); BMI, body mass index; PCOS; polycystic ovarian syndrome; AST, aspartate aminotransferase; ALT, alanine transaminase.